ArticleBlood advances2021

Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.

Evan M Cherry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.